COLL Initiates Coverage On Collegium Pharmaceutical -- Outperform Rating by Oppenheimer

gurufocus.com · 2026-09-23

Collegium Pharmaceutical (COLL) Analyst Rating Update On October 03, 2023, Oppenheimer initiated coverage on Collegium Pharmaceutical (COLL) with an "Outperf

TickrTrends take: Oppenheimer's initiation of coverage with an Outperform rating on Collegium Pharmaceutical aligns with TickrTrends' current assessment that the stock trades at an undervalued level within the Healthcare sector. The analyst endorsement of the company's prospects could support the thesis that the market has not fully reflected the company's potential, particularly relevant for investors focused on valuation metrics. A valuation-focused reader should monitor whether this analyst attention contributes to multiple expansion or whether fundamental metrics continue to suggest the stock remains discounted relative to comparable Healthcare companies.

Read the full story at gurufocus.com →